JP2001503802A - アシル化シクロデキストリン誘導体 - Google Patents
アシル化シクロデキストリン誘導体Info
- Publication number
- JP2001503802A JP2001503802A JP52139498A JP52139498A JP2001503802A JP 2001503802 A JP2001503802 A JP 2001503802A JP 52139498 A JP52139498 A JP 52139498A JP 52139498 A JP52139498 A JP 52139498A JP 2001503802 A JP2001503802 A JP 2001503802A
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- composition
- copolymer
- polypeptide
- cyclodextrin derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
- Y10S530/817—Entrapped within the carrier, e.g. gel, hollow fibre
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.シクロデキストリンの遊離水酸基の少なくとも60%がアシル基によって アシル化されてなり、該アシル基の少なくとも一つは遊離カルボキシル基を含む ことを特徴とするシクロデキストリン誘導体。 2.該シクロデキストリンは、α−シクロデキストリン、β−シクロデキスト リン、またはγ−シクロデキストリンである請求の範囲第1項に記載のシクロデ キストリン誘導体。 3.該アシル基はCOE1またはCOE2から選択され、E1はC2-32のカルボ キシアルキル、C3-32のカルボキシアルケニル、C7-37のカルボキシアリール、 C8-38のカルボキシアリール アルキル、およびC9-39のカルボキシアリール アルケニルからなる群より選択され、E2はC1-30のアルキル、C2-30のアルケ ニル、C6-36のアリール、C7-37のアリールアルケニル、およびC8-38のアリー ルアルケニルからなる群より選択されるものであり、かつ該アシル基の少なくと も一つはCOE1である請求の範囲第2項に記載のシクロデキストリン誘導体。 4.該シクロデキストリンの該遊離水酸基の10から80%は、COE1でア シル化されており、該シクロデキストリンの10から80%はCOE2でアシル 化されている請求の範囲第3項に記載のシクロデキストリン誘導体。 5.COE1はCO(CH2)nCOOH(ただしn=2〜3)で、COE2はC O(CH2)nCH3(ただしn=0〜5)であり、該シクロデキストリンはβ− シクロデキストリンである請求の範囲第4項に記載のシクロデキストリン誘導体 。 6.請求の範囲第1項に記載のシクロデキストリン誘導体からなる共重合体で あって、該シクロデキストリン誘導体は、ヒドロキシ酸単量体からなるポリエス テルでアシル化された少なくともーつの遊離水酸基を含むことを特徴とする共重 合体。 7.該共重合体は500から40,000ダルトンの平均分子量を有する請求 の範囲第6項に記載の共重合体。 8.該ポリエステルは、乳酸、グリコール酸、ヒドロキシカプロン酸およびそ れらの全ての光学活性異性体からなる群より選択されたヒドロキシ酸単量体から なる請求の範囲第7項に記載の共重合体。 9.請求の範囲第5項に記載の該シクロデキストリン誘導体からなる共重合体 であって、該シクロデキストリン誘導体は、ヒドロキシ酸からなるポリエステル でアシル化された少なくとも一つの遊離水酸基を含むことを特徴とする共重合体 。 10.該ポリエステルは、乳酸、グリコール酸、ヒドロキシカプロン酸および それらの全ての光学活性異性体からなる群より選択されたヒドロキシ酸単量体か らなり、該共重合体は500から40,000ダルトンの平均分子量を有する請 求の範囲第9項に記載の共重合体。 11.請求の範囲第1項に記載の該シクロデキストリン誘導体と薬剤を含む組 成物であって、該薬剤は少なくとも一つの有効なイオン性アミンを含み、該組成 物中のポリペプチドの少なくとも50重量%が、イオン的に該シクロデキストリ ン誘導体に結合していることを特徴とする組成物。 12.該組成物は、1から30重量%の該薬剤を含んでいる請求の範囲第11 項に記載の組成物。 13.該薬剤はポリペプチドである請求の範囲第12項に記載の組成物。 14.該ポリペプチドは、4から50個のアミノ酸を含んでいる請求の範囲第 13項に記載の組成物。 15.該ポリペプチドは、ソマトスタチン、黄体ホルモン放出ホルモン、カル シトニンまたはそれらの類似体である請求の範囲第14項に記載の組成物。 16.請求の範囲第6項に記載の該共重合体と薬剤を含む組成物であって、該 薬剤は少なくとも一つの有効なイオン性アミンを含み、該組成物中のポリペプチ ドの少なくとも50重量%が、イオン的に該シクロデキストリン誘導体に結合し ていることを特徴とする組成物。 17.該組成物は、1から30重量%の該薬剤を含んでいる請求の範囲第16 項に記載の組成物。 18.該薬剤はポリペプチドである請求の範囲第17項に記載の組成物。 19.該ポリペプチドは、4から50個のアミノ酸を含んでいる請求の範囲第 18項に記載の組成物。 20.該ポリペプチドは、ソマトスタチン、黄体ホルモン放出ホルモン、カル シトニンまたはそれらの類似体である請求の範囲第19項に記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/740,778 US5916883A (en) | 1996-11-01 | 1996-11-01 | Acylated cyclodextrin derivatives |
US08/740,778 | 1996-11-01 | ||
PCT/US1997/018105 WO1998020044A1 (en) | 1996-11-01 | 1997-10-06 | Acylated cyclodextrin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001503802A true JP2001503802A (ja) | 2001-03-21 |
JP2001503802A5 JP2001503802A5 (ja) | 2005-01-13 |
Family
ID=24978025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52139498A Ceased JP2001503802A (ja) | 1996-11-01 | 1997-10-06 | アシル化シクロデキストリン誘導体 |
Country Status (13)
Country | Link |
---|---|
US (2) | US5916883A (ja) |
EP (1) | EP0935613B1 (ja) |
JP (1) | JP2001503802A (ja) |
AT (1) | ATE219109T1 (ja) |
AU (1) | AU728398B2 (ja) |
CA (1) | CA2269519C (ja) |
DE (1) | DE69713369T2 (ja) |
DK (1) | DK0935613T3 (ja) |
ES (1) | ES2176705T3 (ja) |
IL (1) | IL129652A0 (ja) |
NZ (1) | NZ335387A (ja) |
PT (1) | PT935613E (ja) |
WO (1) | WO1998020044A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006506397A (ja) * | 2002-10-31 | 2006-02-23 | ファイザー・プロダクツ・インク | 固体及び半固体高分子イオン・コンジュゲート |
JP2009270119A (ja) * | 2005-08-31 | 2009-11-19 | Nissan Motor Co Ltd | 疎水性修飾ポリロタキサン |
JP2011037868A (ja) * | 2001-11-05 | 2011-02-24 | Univ Federal De Minas Gerais - Ufmg | シクロデキストリン、リポソーム及び生分解性ポリマー並びに/或いはそれらの混合物及び生成物を用いる、ペプチドアンギオテンシン−(1−7)並びにその類似体、作動薬及び拮抗薬の製剤の調製方法 |
JP2014177602A (ja) * | 2013-03-15 | 2014-09-25 | Institute Of National Colleges Of Technology Japan | 水不溶性シクロデキストリンポリマーおよびその製造方法 |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1286510B1 (it) * | 1996-11-29 | 1998-07-15 | Cooperativa Centro Ricerche Po | Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono |
JP2000026501A (ja) * | 1998-07-10 | 2000-01-25 | Daicel Chem Ind Ltd | アセチル化硝化綿及びその製造方法 |
PL205713B1 (pl) | 1998-12-07 | 2010-05-31 | Sod Conseils Rech Applic | Związki stanowiące analogi GLP-1, kompozycje farmaceutyczne zawierające takie związki oraz zastosowanie tych związków |
JP2003531930A (ja) | 2000-04-28 | 2003-10-28 | ユニバーシティ・カレッジ・ダブリン | 両親媒性大環状誘導体およびそれらの類似体 |
US6566556B2 (en) * | 2000-12-19 | 2003-05-20 | Nippon Shokubai Co., Ltd. | Method for production of alkanolamine and apparatus therefor |
BR0102252B1 (pt) * | 2001-04-10 | 2013-10-22 | Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso | |
US7141540B2 (en) * | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
US7122622B2 (en) * | 2002-04-16 | 2006-10-17 | Biosynthema Inc. | Peptide compounds having improved binding affinity to somatostatin receptors |
US6869939B2 (en) * | 2002-05-04 | 2005-03-22 | Cydex, Inc. | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
US6709746B2 (en) * | 2002-06-05 | 2004-03-23 | Arteva North America S.á.r.l. | Reducing concentration of organic materials with substituted cyclodextrin compound in polyester packaging materials |
BR0315866A (pt) * | 2002-10-31 | 2005-09-27 | Pfizer Prod Inc | Conjugados lìquidos de produtos farmacêuticos sólidos |
US7166671B2 (en) * | 2002-12-10 | 2007-01-23 | Cellresin Technologies, Llc | Grafted cyclodextrin |
US8129450B2 (en) | 2002-12-10 | 2012-03-06 | Cellresin Technologies, Llc | Articles having a polymer grafted cyclodextrin |
US7385004B2 (en) * | 2002-12-10 | 2008-06-10 | Cellresin Technologies, Llc | Enhanced lubrication in polyolefin closure with polyolefin grafted cyclodextrin |
SE0303179D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
ES2393335T3 (es) | 2003-12-16 | 2012-12-20 | Ipsen Pharma | Análogos de GLP-1 |
ES2350397T3 (es) * | 2004-05-24 | 2011-01-21 | Cellresin Technologies, Llc | Materiales de barrera anfóteros injertados. |
DK3354273T3 (da) | 2005-07-08 | 2021-06-28 | Ipsen Pharma | Melanocortinreceptorligander |
ES2855700T3 (es) | 2007-04-27 | 2021-09-24 | Cydex Pharmaceuticals Inc | Formulaciones que contienen clopidogrel y sulfoalquil éter-ciclodextrina y métodos de uso |
US20090060860A1 (en) * | 2007-08-31 | 2009-03-05 | Eva Almenar | Beta-cyclodextrins as nucleating agents for poly(lactic acid) |
EP2200626A4 (en) | 2007-09-07 | 2012-02-15 | Ipsen Pharma Sas | ANALOGUE OF EXENDIN-4 AND EXENDIN-3 |
RU2453328C2 (ru) | 2007-11-05 | 2012-06-20 | Ипсен Фарма С.А.С. | Применение меланокортинов для лечения чувствительности к инсулину |
MX2011000147A (es) | 2008-07-04 | 2011-05-24 | Traslational Cancer Drugs Pharma S L | Metodos para el tratamiento y diagnostico del cancer. |
AU2009280012B2 (en) | 2008-08-07 | 2012-12-06 | Ipsen Pharma S.A.S. | Truncated analogues of glucose-dependent insulinotropic polypeptide |
CN102171244B (zh) | 2008-08-07 | 2015-05-13 | 益普生制药股份有限公司 | 糖依赖性胰岛素释放肽的类似物 |
EA020091B1 (ru) | 2008-08-07 | 2014-08-29 | Ипсен Фарма С.А.С. | Аналоги глюкозозависимого инсулинотропного полипептида (gip), модифицированные по n-концу |
WO2010053487A1 (en) | 2008-11-07 | 2010-05-14 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
CN102316892B (zh) | 2009-02-12 | 2014-06-04 | 西马生物医学计划公司 | 心肌营养素-1用于治疗代谢病的用途 |
HUE047755T2 (hu) * | 2009-05-13 | 2020-05-28 | Cydex Pharmaceuticals Inc | Prasugrelt és ciklodextrin-származékokat tartalmazó gyógyszerkészítmények, eljárás ezek elõállítására és alkalmazásra |
US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
PL2434886T3 (pl) | 2009-05-29 | 2020-05-18 | Cydex Pharmaceuticals, Inc. | Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania |
BR112012001363A2 (pt) | 2009-07-22 | 2016-11-08 | Ipsen Pharma Sas | análogo de igf-1, composição farmacêutica,e, método para tratar condições ou doenças mediadas pela ligação do receptor de igf-1 |
CN105561330B (zh) * | 2016-01-25 | 2018-05-25 | 四川大学 | 一种人降钙素-葫芦脲复合制剂及其制备方法 |
CN112759667A (zh) * | 2021-01-05 | 2021-05-07 | 淄博千汇生物科技有限公司 | 一种三乙酰基-β-环糊精的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3426011A (en) * | 1967-02-13 | 1969-02-04 | Corn Products Co | Cyclodextrins with anionic properties |
US3453260A (en) * | 1967-03-22 | 1969-07-01 | Corn Products Co | Cyclic anhydride esters of cyclodextrin |
US4659696A (en) | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
CH656884A5 (de) * | 1983-08-26 | 1986-07-31 | Sandoz Ag | Polyolester, deren herstellung und verwendung. |
US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
JPH0819004B2 (ja) * | 1986-12-26 | 1996-02-28 | 日清製粉株式会社 | 徐放性医薬製剤 |
US5658894A (en) * | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
US5183809A (en) * | 1990-02-15 | 1993-02-02 | The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation | Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
US5247013A (en) * | 1989-01-27 | 1993-09-21 | Mitsui Toatsu Chemicals, Inc. | Biocompatible polyester and production thereof |
EP0485614B1 (en) * | 1990-05-21 | 1997-08-13 | Toppan Printing Co., Ltd. | Cyclodextrin derivative |
US5208316A (en) * | 1990-10-01 | 1993-05-04 | Toppan Printing Co., Ltd. | Cyclodextrin polymer and cyclodextrin membrane prepared using said polymer |
US5287850A (en) * | 1991-08-20 | 1994-02-22 | Habley Medical Technology Corporation | Timing and velocity controlled powered pharmaceutical inhaler |
JPH06100464A (ja) * | 1992-06-08 | 1994-04-12 | Asahi Chem Ind Co Ltd | カルシトニン類の経肺投与用組成物 |
US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
DE4414128A1 (de) * | 1994-04-22 | 1995-10-26 | Consortium Elektrochem Ind | Teilweise acylierte beta-Cyclodextrine |
BE1008978A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
-
1996
- 1996-11-01 US US08/740,778 patent/US5916883A/en not_active Expired - Lifetime
-
1997
- 1997-10-06 WO PCT/US1997/018105 patent/WO1998020044A1/en active IP Right Grant
- 1997-10-06 PT PT97910005T patent/PT935613E/pt unknown
- 1997-10-06 ES ES97910005T patent/ES2176705T3/es not_active Expired - Lifetime
- 1997-10-06 AT AT97910005T patent/ATE219109T1/de not_active IP Right Cessation
- 1997-10-06 DK DK97910005T patent/DK0935613T3/da active
- 1997-10-06 DE DE69713369T patent/DE69713369T2/de not_active Expired - Fee Related
- 1997-10-06 IL IL12965297A patent/IL129652A0/xx unknown
- 1997-10-06 EP EP97910005A patent/EP0935613B1/en not_active Expired - Lifetime
- 1997-10-06 NZ NZ335387A patent/NZ335387A/en unknown
- 1997-10-06 JP JP52139498A patent/JP2001503802A/ja not_active Ceased
- 1997-10-06 AU AU47483/97A patent/AU728398B2/en not_active Ceased
- 1997-10-06 CA CA002269519A patent/CA2269519C/en not_active Expired - Fee Related
-
1999
- 1999-04-08 US US09/288,471 patent/US6204256B1/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011037868A (ja) * | 2001-11-05 | 2011-02-24 | Univ Federal De Minas Gerais - Ufmg | シクロデキストリン、リポソーム及び生分解性ポリマー並びに/或いはそれらの混合物及び生成物を用いる、ペプチドアンギオテンシン−(1−7)並びにその類似体、作動薬及び拮抗薬の製剤の調製方法 |
JP2006506397A (ja) * | 2002-10-31 | 2006-02-23 | ファイザー・プロダクツ・インク | 固体及び半固体高分子イオン・コンジュゲート |
JP2009270119A (ja) * | 2005-08-31 | 2009-11-19 | Nissan Motor Co Ltd | 疎水性修飾ポリロタキサン |
JP2014177602A (ja) * | 2013-03-15 | 2014-09-25 | Institute Of National Colleges Of Technology Japan | 水不溶性シクロデキストリンポリマーおよびその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
EP0935613A1 (en) | 1999-08-18 |
CA2269519A1 (en) | 1998-05-14 |
DE69713369T2 (de) | 2003-02-13 |
EP0935613B1 (en) | 2002-06-12 |
PT935613E (pt) | 2002-11-29 |
DE69713369D1 (de) | 2002-07-18 |
IL129652A0 (en) | 2000-02-29 |
AU4748397A (en) | 1998-05-29 |
ES2176705T3 (es) | 2002-12-01 |
WO1998020044A1 (en) | 1998-05-14 |
DK0935613T3 (da) | 2002-10-07 |
AU728398B2 (en) | 2001-01-11 |
NZ335387A (en) | 2001-05-25 |
US6204256B1 (en) | 2001-03-20 |
ATE219109T1 (de) | 2002-06-15 |
CA2269519C (en) | 2007-01-09 |
US5916883A (en) | 1999-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001503802A (ja) | アシル化シクロデキストリン誘導体 | |
JP5737843B2 (ja) | 生理活性分子の向上した送達のための方法及び組成物 | |
JP3990614B2 (ja) | 生物分解性ポリエステルおよび生物活性ポリペプチドのイオン分子結合体 | |
CA2214889C (en) | Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof | |
EP1906928B1 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
JPH11508289A (ja) | ポリ(2−アミノ−2−デオキシ−d−グルコース)のn−アシル化誘導体とポリペプチド類とのイオン性分子結合体 | |
HU220137B (hu) | Biológiailag lebontható poliészterek és biológiailag aktív polipeptidek ionos molekuláris konjugátumai, eljárás ezek előállítására és eljárás mikrorészecskék előállítására | |
AU2002220002A1 (en) | Methods and compositions for enhanced delivery of bioactive molecules | |
JP2002530345A (ja) | 鉄−デキストラン化合物の製造法 | |
WO2021157665A1 (ja) | ヒアルロン酸誘導体、医薬組成物及びヒアルロン酸誘導体-薬物結合体 | |
US20090257975A1 (en) | Solid and Semi-Solid Polymeric Ionic Conjugates | |
JP2002522596A (ja) | リン酸化ポリマー及びその複合体 | |
Zhang et al. | Synthesis and bioactivity of cellulose derivatives | |
EP1212095B1 (en) | Process to make a sustained release formulation | |
WO2007116965A1 (ja) | グラフトポリマーとカルシウム化合物とを含む微粒子 | |
MXPA99003959A (en) | Acylated cyclodextrin derivatives | |
US20030092800A1 (en) | Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides | |
CN108434120B (zh) | 一种口服胰岛素纳米颗粒及其制备方法 | |
Arunprasert et al. | Synthesis and evaluation of poly (ethylene glycol) diacrylate-modified chitosan as a mucoadhesive polymer:(TJPS-2020-0138. R1) | |
NZ533103A (en) | Depot medicament, carrier materials for depot medicaments, and method for the production thereof | |
IES940005A2 (en) | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040413 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040413 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070911 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080130 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080311 |